ArticleBMC cancer2024

Molecular heterogeneity and treatment outcome of EGFR exon 20 insertion mutations in Chinese patients with advanced non-small cell lung cancer: insights from a large-scale real-world study.

Weirui Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.